felix granovskiy
Published 11 years ago • 146 plays • Length 3:49Download video MP4
Download video MP3
Similar videos
-
2:25
neurosurgeon dr. glenn keiper: aspen® mis fusion system
-
2:00
parkinson's disease (2021)
-
58:39
parkinson's disease and multiple system atrohpy with a touch of covid - with dr victor dieriks
-
32:06
dr julian furby - dmts in progressive ms
-
1:37
ad/pd™ speakers - prof. henrik zetterberg
-
10:28
progress in genetic therapies for als
-
3:27
new breakthrough treatment hoping to stop progression of multiple sclerosis | your morning
-
24:40
approach to the evaluation of msa (multiple system atrophy) - brad hiner, md
-
1:21
dr. friedman on the future of selinexor in multiple myeloma
-
3:24
unraveling subtypes of parkinson's disease: a focus on biomarkers
-
1:52
gnosis by lesaffre academy - probiotic bacteria
-
6:50
should findings from monogenic dementias inform sporadic disease research?
-
2:17
anti-inflammatory strategies for neuroprotection in parkinson’s disease
-
2:28
prof. feliks nuske, max-planck-institute for dynamics of complex technical systems - fers school
-
1:03
the spread of pathology in parkinson’s disease
-
2:27
horizon scanning in treating disease progression in ms
-
1:08
neuroregenerative agents in progressive multiple sclerosis
-
1:11
amd3100 in animal models of als and ms
-
47:40
“psychedelics as antidepressants: a potential link between depression and the fibrinolytic system”
-
0:35
jeffrey glick, md
-
2:50
insights into parkinson’s disease pathology: α-syn & phosphoinositides
-
2:05
alpha-synuclein inhibitors, kinase inhibitors & targeting mitochondria in parkinson’s disease